KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Other Non-Current Liabilities (2019 - 2025)

Castle Biosciences (CSTL) has disclosed Other Non-Current Liabilities for 6 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities changed N/A to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, changed N/A year-over-year, with the annual reading at $1.5 million for FY2025, N/A changed from the prior year.
  • Other Non-Current Liabilities hit $1.5 million in Q4 2025 for Castle Biosciences, roughly flat from $1.5 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $18.3 million in Q4 2021 to a low of $3000.0 in Q3 2021.
  • Historically, Other Non-Current Liabilities has averaged $1.7 million across 5 years, with a median of $90000.0 in 2022.
  • Biggest YoY gain for Other Non-Current Liabilities was 59833.33% in 2022; the steepest drop was 99.51% in 2022.
  • Year by year, Other Non-Current Liabilities stood at $18.3 million in 2021, then tumbled by 99.51% to $90000.0 in 2022, then tumbled by 72.22% to $25000.0 in 2023, then crashed by 36.0% to $16000.0 in 2024, then soared by 9275.0% to $1.5 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for CSTL at $1.5 million in Q4 2025, $1.5 million in Q3 2025, and $1.5 million in Q2 2025.